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Prion mechanism as 
clinical strategy? 
-­‐	  Diseases  caused  by  proteins  with  excess  of  activity  -­‐  Pathogens
Figure  4  |  Position  PrionScan-­‐PAPA  correlation  graphic.
Figure  3  |  Score  PrionScan-­‐PAPA  correlation  graphic.
A  fascinating  and  potentially  revolutionary  new  concept  is   emerging   in   several   neurodegenerative   diseases.   It  involves   the   propagation   of   RNA-­‐protein   aggregates  from   cell   to   cell   during   the   onset   and   progression   of  diseases.   It   now   appears   that   many   ‘‘protein-­‐folding’’  diseases,   such   as   Alzheimer’s   and   Parkinson’s   diseases,  can   be   transmitted   between   cells   by   a   prion-­‐like  mechanism.  
RNA-­‐binding	  proteins	  aﬀect	  pre-­‐mRNA	  processing	  and	  are	  
transported	  with	  the	  mRNA	  to	  the	  cytosol,	  where	  they	  are	  
removed	   by	   transla;on-­‐dependent	   and	   independent	  
mechanisms	   for	   recycling	   into	   the	   nucleus.	   Once	   into	   the	  
cytosol,	  when	  mRNAs	  are	  not	  engaged	   in	   transla;on,	   they	  
assemble	  into	  P	  bodies	  or	  Stress	  Granules	  (SGs).	  Figure  1  |  mRNP  Remodeling  and  Aggregation  in  the  lifecycle  of  an  mRNA  [1].  
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Concluding Remarks 
Introduction: Prionoids & RNA-binding Proteins 
Algorithms to detect prion-like domains  
Cellular  stress   induces  FUS/TLS  or  HNRNPD  incorporation  into  stress  granules,  which  form  through  the  ordered  aggregation  of  several  RNA-­‐binding  proteins  complexed  RNA  molecules.  This  physiologic  reaction  to  cellular  stress  may  be  an  initial  trigger  for  pathogenic  inclusion  formation,  given  that  the  increased   local   protein   concentration   and   RNA   scaffolding   molecules   may   facilitate   ordered  aggregation  of  FUS/TLS  or  HNRNPD.   In   this  context,   the   functional  conformational  changes  of   these  two  proteins  associated  with  their  physiological  roles  in  stress  granule  formation  may  transform  into  pathogenic,   self-­‐perpetuating,   irreversible   aggregation   upon   chronic   cellular   stress   and   defects   in  stress  granule  disassembly  occurring  with  aging.  Possible  cell-­‐to-­‐cell  spread  of  prion-­‐like  aggregates  may  underline  or  contribute  to  disease  spread  from  a  focal  initiation.  
Identifying  solutions  for  correcting  defective  RNA  and  protein  proteostasis  
Animals 
models prion-­‐domain  prediction  with  the  aggregation-­‐prone
New 
Algorithms 














FUS/TLS & HNRNPD 
Prion mechanism 
Implication in disease RNA-­‐  Binding  Protein
Gene Disease Mutation Location Mechanism   ProcessFUS ALS(Amyotrophic  lateral  sclerosis) Missesense,  nonsense,  in/del,  splicing Exons.  (Protein  domains:  NLS,  NES,  Prion-­‐like) RNA  gain  of  function FUS  protein  aggregates  ETM4(Hereditary  essential  tremor  4) Missense,  nonsense Exons RNA  loss  of  function UnknownFTLD(Frontotemporal  lobar  degeneration) Missense Exons,  splice  sites Unknown FUS  protein  aggregates  
Leukemia  and  Sarcoma Translocation  transcription  factor Prion-­‐like  domain Dysfunction  transcription  factor Misfolding,  aberrant  oligomerizationHNRNPD  (Determined  by  similarity  with  RNA-­‐binding  proteins)  




Figure  5  |Domains  and  disease  mutations  of  FUS  [2]. Figure  6  |Domains  and  motifs  of  HNRNPD.   
Figure  7  |  Proposed  functions  for  FUS/TLS  [3].    
Figure  8  |  Aggregate  Assembly  and  Propagation  for  FUS/TLS  and  HNRNPD.  Figure  adapted  from  [4].  
Figure  9  |  Models  for  the  Selective  Sensitivity  of  Neurons  to  Altered  Ribostasis  [1].  
Table  1   |  FUS  and  HNRNPD  Human  RNA-­‐  binding  proteins  with  prion-­‐like  domains.  FUS  and  HNRNPD  human  proteins  were   scanned   for   prion-­‐like   domains   using   the   PAPA   and   PrionScan   algorithms.   The   location   of   the  prion-­‐like  domain  and  a  core  region  of  highest  score  are  provided.  
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•  RNA-­‐binding  proteins  contain  such  prion-­‐like  domains  or  low  complexity  (LC)  domains:  mediate  assembly  into  higher-­‐order  structures    
•  Bioinformatic  algorithms  detect  LCs  domainsFigure  2  |  Normal  Stress  Granule  Dynamics  and  Possible  Evolution  of  Pathogenic  Inclusions  [1].  
Nucleus   and   cytoplasm   are   the   subcellular   localization   of   these   two  proteins.  The  FUS  functions  are  represented  in  Figure  7.  HNRNPD  is  present  in  a  big  amount  of  biological  processes  as  FUS:  RNA  catabolic  process,  RNA  metabolic  process,  RNA  processing,  RNA  splicing,  gene   expression,   mRNA   metabolic   process,   mRNA   splicing   (via  spliceosome),   regulation   of   mRNA   stability   and   regulation   of  transcription  (DNA-­‐templated),  poly(A)  RNA  binding  and  telomeric  DNA  binding.
Cellular localization and function 
